{"id":320,"date":"2025-05-02T08:15:00","date_gmt":"2025-05-02T06:15:00","guid":{"rendered":"https:\/\/maag.codesupply.co\/gear\/?p=320"},"modified":"2025-05-14T22:38:15","modified_gmt":"2025-05-14T20:38:15","slug":"mastering-the-art-of-personal-time-management","status":"publish","type":"post","link":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/","title":{"rendered":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD"},"content":{"rendered":"\n

Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?<\/strong> To pytanie coraz cz\u0119\u015bciej zadaj\u0105 sobie nie tylko naukowcy, ale i inwestorzy. Odpowiedzi\u0105 na nie mo\u017ce by\u0107 NewLimit<\/strong> \u2013 ameryka\u0144ski startup, kt\u00f3ry od momentu powstania wzbudza ogromne emocje w \u015bwiecie medycyny, nauki o starzeniu si\u0119 i venture capital.<\/p>\n\n\n\n

\n

„Naszym celem jest opracowanie lek\u00f3w, kt\u00f3re przywracaj\u0105 m\u0142odo\u015b\u0107 wielu typom kom\u00f3rek. Wierzymy, \u017ce po\u0142\u0105czenie epigenetyki i sztucznej inteligencji mo\u017ce odblokowa\u0107 terapie, kt\u00f3re dodadz\u0105 ka\u017cdemu z nas wi\u0119cej zdrowych lat \u017cycia.”<\/p>\nKleiner Perkins CEO NewLimit <\/cite><\/blockquote>\n\n\n\n

<\/p>\n\n\n\n

Co robi NewLimit?<\/h2>\n\n\n\n

Aktualnie firma koncentruje si\u0119 na:<\/p>\n\n\n\n

\u2022 Rozwijaniu bibliotek kom\u00f3rkowych<\/strong>, kt\u00f3re s\u0105 poddawane modyfikacjom epigenetycznym<\/p>\n\n\n\n

\u2022 Mapowaniu efekt\u00f3w tych modyfikacji<\/strong> na starzenie si\u0119 i ekspresj\u0119 gen\u00f3w<\/p>\n\n\n\n

\u2022 Projektowaniu terapii pierwszej generacji<\/strong> \u2013 prawdopodobnie dla chor\u00f3b neurodegeneracyjnych, takich jak choroba Alzheimera<\/strong> czy zaniki mi\u0119\u015bniowe<\/strong><\/p>\n\n\n\n

Pierwsze badania przedkliniczne s\u0105 ju\u017c w toku, a firma planuje rozpocz\u0105\u0107 badania kliniczne do ko\u0144ca 2026 r.<\/p>\n\n\n\n

\"Kleiner
Kleiner Perkins CEO NewLimit Age-tech startup<\/figcaption><\/figure>\n\n\n\n

Czym jest NewLimit?<\/h2>\n\n\n\n

NewLimit to biotechnologiczna firma z siedzib\u0105 w San Francisco, za\u0142o\u017cona przez by\u0142ego wsp\u00f3\u0142tw\u00f3rc\u0119 Coinbase \u2013 Briana Armstronga \u2013 i Blake\u2019a Byers\u2019a (Byers Capital). Jej g\u0142\u00f3wnym celem jest opracowanie terapii epigenetycznych<\/strong>, kt\u00f3re pozwol\u0105 \u201ezresetowa\u0107\u201d kom\u00f3rki organizmu do bardziej m\u0142odzie\u0144czego stanu bez konieczno\u015bci ich pe\u0142nej reprogramacji. Dzi\u0119ki temu mo\u017cliwe by\u0142oby leczenie, a by\u0107 mo\u017ce w przysz\u0142o\u015bci nawet cofanie efekt\u00f3w starzenia.<\/p>\n\n\n\n

Technologia opiera si\u0119 na modyfikacji ekspresji gen\u00f3w<\/strong> bez zmieniania sekwencji DNA \u2013 to tzw. reprogramowanie epigenetyczne<\/strong>, uznawane dzi\u015b za jedno z najbardziej obiecuj\u0105cych podej\u015b\u0107 w medycynie regeneracyjnej.<\/p>\n\n\n\n

Rekordowe finansowanie \u2013 130 milion\u00f3w dolar\u00f3w w 2025 r.<\/h2>\n\n\n\n

W maju 2025 roku NewLimit og\u0142osi\u0142 zako\u0144czenie rundy finansowania serii B, w kt\u00f3rej pozyska\u0142 130 milion\u00f3w dolar\u00f3w<\/strong>. To jedno z najwi\u0119kszych tegorocznych finansowa\u0144 w sektorze AgeTech i longevity. W rundzie udzia\u0142 wzi\u0119li giganci rynku VC:<\/p>\n\n\n\n

\u2022 Kleiner Perkins<\/p>\n\n\n\n

\u2022 Khosla Ventures<\/p>\n\n\n\n

\u2022 Founders Fund<\/p>\n\n\n\n

\u2022 Byers Capital<\/p>\n\n\n\n

\u2022 oraz kilku strategicznych inwestor\u00f3w z sektora healthcare i AI<\/p>\n\n\n\n

To nie pierwszy sukces finansowy NewLimit \u2013 wcze\u015bniej, w rundzie seed i serii A, firma pozyska\u0142a \u0142\u0105cznie ponad 50 milion\u00f3w dolar\u00f3w. Warto zaznaczy\u0107, \u017ce ju\u017c w 2023 r. by\u0142a wyceniana na ponad $500 milion\u00f3w<\/strong> \u2013 dzi\u015b ta liczba mo\u017ce by\u0107 jeszcze wy\u017csza.<\/p>\n\n\n\n

To nie pierwszy sukces finansowy NewLimit \u2013 wcze\u015bniej, w rundzie seed i serii A, firma pozyska\u0142a \u0142\u0105cznie ponad 50 milion\u00f3w dolar\u00f3w. Warto zaznaczy\u0107, \u017ce ju\u017c w 2023 r. by\u0142a wyceniana na ponad $500 milion\u00f3w<\/strong> \u2013 dzi\u015b ta liczba mo\u017ce by\u0107 jeszcze wy\u017csza.<\/p>\n\n\n\n

Dlaczego inwestorzy wierz\u0105 w NewLimit?<\/h2>\n\n\n\n
    \n
  1. Ogromny rynek docelowy<\/li>\n<\/ol>\n\n\n\n

    Wed\u0142ug danych WHO, liczba os\u00f3b w wieku 65+ wzro\u015bnie do 1,6 miliarda<\/strong> do 2050 roku. Starzenie si\u0119 to najwi\u0119kszy czynnik ryzyka dla wi\u0119kszo\u015bci chor\u00f3b przewlek\u0142ych \u2013 od Alzheimera po choroby serca.<\/p>\n\n\n\n

    Rynek terapii anty-aging i longevity szacowany jest dzi\u015b na ponad $25 miliard\u00f3w<\/strong>, a do 2030 r. ma przekroczy\u0107 $50 miliard\u00f3w (\u017ar\u00f3d\u0142o: Global Market Insights).<\/p>\n\n\n\n

    2. Nowa fala neuronauki i epigenetyki<\/p>\n\n\n\n

    Epigenetyczne modyfikacje to nie tylko science fiction \u2013 pierwsze badania kliniczne (np. z u\u017cyciem tzw. Yamanaka Factors) pokazuj\u0105 realny potencja\u0142 do regeneracji kom\u00f3rek i op\u00f3\u017anienia chor\u00f3b neurodegeneracyjnych.<\/p>\n\n\n\n

    3. Zesp\u00f3\u0142 z topowej ligi<\/p>\n\n\n\n

    NewLimit zatrudnia by\u0142ych naukowc\u00f3w z MIT, Stanford i Harvardu, a ich doradcy naukowi to \u015bwiatowe autorytety w dziedzinie epigenetyki, biologii molekularnej i aging science.<\/p>\n\n\n\n

    4. Konwergencja AI + biotech<\/p>\n\n\n\n

    Firma rozwija tak\u017ce platformy oparte na sztucznej inteligencji do przewidywania i analizowania efekt\u00f3w modyfikacji epigenetycznych \u2013 co przyspiesza badania i zmniejsza ryzyko pora\u017cek.<\/p>\n\n\n\n

    Podsumowanie \u2013 Co oznacza NewLimit dla rynku AgeTech?<\/h2>\n\n\n\n

    NewLimit to wi\u0119cej ni\u017c tylko startup \u2013 to symbol nowej ery medycyny. Jego sukces finansowy i naukowy pokazuje, \u017ce inwestowanie w d\u0142ugowieczno\u015b\u0107 i neuronauk\u0119 nie jest ju\u017c ekstrawagancj\u0105, lecz logiczn\u0105 strategi\u0105 VC<\/strong>. Firma wpisuje si\u0119 w szerszy kontekst rozwoju AgeTech<\/strong>, czyli technologii wspieraj\u0105cych zdrowe i aktywne starzenie si\u0119.<\/p>\n\n\n\n

    Wraz z rosn\u0105cym wiekiem populacji i rosn\u0105cym zainteresowaniem jako\u015bci\u0105 \u017cycia po 60. roku \u017cycia, projekty takie jak NewLimit maj\u0105 szans\u0119 zmieni\u0107 paradygmat opieki zdrowotnej \u2013 z leczenia na prewencj\u0119 i regeneracj\u0119<\/strong>.<\/p>\n\n\n\n

    BG<\/p>\n\n\n\n

    <\/p>\n","protected":false},"excerpt":{"rendered":"Celem NewLimit jest opracowanie terapii epigenetycznych, kt\u00f3re pozwol\u0105 \u201ezresetowa\u0107\u201d kom\u00f3rki organizmu do bardziej m\u0142odzie\u0144czego stanu.","protected":false},"author":1,"featured_media":3213,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[39,3],"tags":[13,8,28],"class_list":["post-320","post","type-post","status-publish","format-standard","has-post-thumbnail","category-inwestycje-w-technologie-agetech","category-zdrowie-seniorow","tag-dobrostan","tag-startup","tag-vc","cs-entry","cs-video-wrap"],"yoast_head":"\nStartup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska<\/title>\n<meta name=\"description\" content=\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska\" \/>\n<meta property=\"og:description\" content=\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\" \/>\n<meta property=\"og:site_name\" content=\"AgeTech Polska\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-02T06:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-14T20:38:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Redakcja AgeTech\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redakcja AgeTech\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\"},\"author\":{\"name\":\"Redakcja AgeTech\",\"@id\":\"https:\/\/agetech.pl\/#\/schema\/person\/9e2ac4d599c438fec64791b6ea8a5da4\"},\"headline\":\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD\",\"datePublished\":\"2025-05-02T06:15:00+00:00\",\"dateModified\":\"2025-05-14T20:38:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\"},\"wordCount\":693,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/agetech.pl\/#organization\"},\"image\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp\",\"keywords\":[\"Dobrostan\",\"Startup\",\"VC\"],\"articleSection\":[\"Inwestycje\",\"Zdrowie\"],\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\",\"url\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\",\"name\":\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska\",\"isPartOf\":{\"@id\":\"https:\/\/agetech.pl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp\",\"datePublished\":\"2025-05-02T06:15:00+00:00\",\"dateModified\":\"2025-05-14T20:38:15+00:00\",\"description\":\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?\",\"breadcrumb\":{\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage\",\"url\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp\",\"contentUrl\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp\",\"width\":2000,\"height\":1333,\"caption\":\"New Limit Startup med tech - age tech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\/\/agetech.pl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/agetech.pl\/#website\",\"url\":\"https:\/\/agetech.pl\/\",\"name\":\"AgeTech Polska\",\"description\":\"AgeTech Polska to pierwszy w Polsce portal po\u015bwi\u0119cony technologiom i innowacjom dla starzej\u0105cego si\u0119 spo\u0142ecze\u0144stwa.\",\"publisher\":{\"@id\":\"https:\/\/agetech.pl\/#organization\"},\"alternateName\":\"AgeTech Poland\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/agetech.pl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/agetech.pl\/#organization\",\"name\":\"AgeTech Polska\",\"url\":\"https:\/\/agetech.pl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\/\/agetech.pl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2025\/05\/ksenia-emelianchik-i-CJpO_SzzU-unsplash-scaled.jpg\",\"contentUrl\":\"https:\/\/agetech.pl\/wp-content\/uploads\/2025\/05\/ksenia-emelianchik-i-CJpO_SzzU-unsplash-scaled.jpg\",\"width\":1707,\"height\":2560,\"caption\":\"AgeTech Polska\"},\"image\":{\"@id\":\"https:\/\/agetech.pl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/agetech-polska\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/agetech.pl\/#\/schema\/person\/9e2ac4d599c438fec64791b6ea8a5da4\",\"name\":\"Redakcja AgeTech\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\/\/agetech.pl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d89b415d5ea10075306c002971bccbed5ffbe3f60c4e1af7f95af9de40ac5785?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d89b415d5ea10075306c002971bccbed5ffbe3f60c4e1af7f95af9de40ac5785?s=96&d=mm&r=g\",\"caption\":\"Redakcja AgeTech\"},\"sameAs\":[\"http:\/\/serwer2080635.home.pl\/autoinstalator\/wordpress\"],\"url\":\"https:\/\/agetech.pl\/index.php\/author\/adminagetech\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska","description":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/","og_locale":"pl_PL","og_type":"article","og_title":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska","og_description":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?","og_url":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/","og_site_name":"AgeTech Polska","article_published_time":"2025-05-02T06:15:00+00:00","article_modified_time":"2025-05-14T20:38:15+00:00","og_image":[{"width":2000,"height":1333,"url":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","type":"image\/webp"}],"author":"Redakcja AgeTech","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"Redakcja AgeTech","Szacowany czas czytania":"4 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#article","isPartOf":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/"},"author":{"name":"Redakcja AgeTech","@id":"https:\/\/agetech.pl\/#\/schema\/person\/9e2ac4d599c438fec64791b6ea8a5da4"},"headline":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD","datePublished":"2025-05-02T06:15:00+00:00","dateModified":"2025-05-14T20:38:15+00:00","mainEntityOfPage":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/"},"wordCount":693,"commentCount":0,"publisher":{"@id":"https:\/\/agetech.pl\/#organization"},"image":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage"},"thumbnailUrl":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","keywords":["Dobrostan","Startup","VC"],"articleSection":["Inwestycje","Zdrowie"],"inLanguage":"pl-PL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/","url":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/","name":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD - AgeTech Polska","isPartOf":{"@id":"https:\/\/agetech.pl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage"},"image":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage"},"thumbnailUrl":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","datePublished":"2025-05-02T06:15:00+00:00","dateModified":"2025-05-14T20:38:15+00:00","description":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD. Czy medycyna mo\u017ce nie tylko leczy\u0107, ale tak\u017ce cofa\u0107 czas?","breadcrumb":{"@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#primaryimage","url":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","contentUrl":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","width":2000,"height":1333,"caption":"New Limit Startup med tech - age tech"},{"@type":"BreadcrumbList","@id":"https:\/\/agetech.pl\/index.php\/2025\/05\/02\/mastering-the-art-of-personal-time-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/agetech.pl\/"},{"@type":"ListItem","position":2,"name":"Startup NewLimit \u2013 Nadzieja na d\u0142u\u017csze, zdrowsze \u017cycie pozyska\u0142 130 mln USD"}]},{"@type":"WebSite","@id":"https:\/\/agetech.pl\/#website","url":"https:\/\/agetech.pl\/","name":"AgeTech Polska","description":"AgeTech Polska to pierwszy w Polsce portal po\u015bwi\u0119cony technologiom i innowacjom dla starzej\u0105cego si\u0119 spo\u0142ecze\u0144stwa.","publisher":{"@id":"https:\/\/agetech.pl\/#organization"},"alternateName":"AgeTech Poland","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/agetech.pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/agetech.pl\/#organization","name":"AgeTech Polska","url":"https:\/\/agetech.pl\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/agetech.pl\/#\/schema\/logo\/image\/","url":"https:\/\/agetech.pl\/wp-content\/uploads\/2025\/05\/ksenia-emelianchik-i-CJpO_SzzU-unsplash-scaled.jpg","contentUrl":"https:\/\/agetech.pl\/wp-content\/uploads\/2025\/05\/ksenia-emelianchik-i-CJpO_SzzU-unsplash-scaled.jpg","width":1707,"height":2560,"caption":"AgeTech Polska"},"image":{"@id":"https:\/\/agetech.pl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/agetech-polska\/"]},{"@type":"Person","@id":"https:\/\/agetech.pl\/#\/schema\/person\/9e2ac4d599c438fec64791b6ea8a5da4","name":"Redakcja AgeTech","image":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/agetech.pl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d89b415d5ea10075306c002971bccbed5ffbe3f60c4e1af7f95af9de40ac5785?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d89b415d5ea10075306c002971bccbed5ffbe3f60c4e1af7f95af9de40ac5785?s=96&d=mm&r=g","caption":"Redakcja AgeTech"},"sameAs":["http:\/\/serwer2080635.home.pl\/autoinstalator\/wordpress"],"url":"https:\/\/agetech.pl\/index.php\/author\/adminagetech\/"}]}},"jetpack_featured_media_url":"https:\/\/agetech.pl\/wp-content\/uploads\/2023\/06\/new-limit-startup-age-tech.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/posts\/320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/comments?post=320"}],"version-history":[{"count":4,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/posts\/320\/revisions"}],"predecessor-version":[{"id":3220,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/posts\/320\/revisions\/3220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/media\/3213"}],"wp:attachment":[{"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/media?parent=320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/categories?post=320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/agetech.pl\/index.php\/wp-json\/wp\/v2\/tags?post=320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}